*]:pointer-events-auto scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" tabindex="-1" data-turn-id= "e42a2a6c-9e77-4666-b10e-7691827934f9" data-testid= "conversation-turn-2" data-scroll-anchor="false" data-turn= "assistant">

Dr. Ashwin Singh Parihar speaks with Dr. Gary Ulaner about new research comparing FDG PET-CT and conventional imaging for detecting oligometastatic breast cancer. They explore how advanced imaging can improve staging accuracy, the challenges of detecting lobular cancer, and the evolving role of targeted therapies in this emerging field.

18F-FDG PET/CT of Oligometastatic Disease in LocallyAdvanced Breast Cancer: PETABC Trial Post Hoc Analysis. Metser et al. adiology 2025; 316(2):e243788.

Detection of Oligometastatic Disease in Breast Cancer:It's the Little Things That Count. Ulaner. Radiology 2025; 316(2):e251797.

*]:pointer-events-auto scroll-mt-(--header-height)" dir="auto" tabindex="-1" data-turn-id= "9d3f7fd2-373c-4ad3-b3a6-9ecb2673123d" data-testid= "conversation-turn-3" data-scroll-anchor="false" data-turn="user">